$0.75 Earnings Per Share Expected for Azul SA (NYSE:AZUL) This Quarter

Share on StockTwits

Equities analysts predict that Azul SA (NYSE:AZUL) will report earnings per share of $0.75 for the current fiscal quarter, Zacks Investment Research reports. Two analysts have issued estimates for Azul’s earnings, with the highest EPS estimate coming in at $0.84 and the lowest estimate coming in at $0.65. Azul reported earnings of $0.31 per share during the same quarter last year, which would suggest a positive year over year growth rate of 141.9%. The business is expected to report its next quarterly earnings report on Thursday, March 12th.

On average, analysts expect that Azul will report full-year earnings of $2.21 per share for the current fiscal year, with EPS estimates ranging from $0.89 to $3.88. For the next fiscal year, analysts anticipate that the business will post earnings of $2.52 per share, with EPS estimates ranging from $2.04 to $3.50. Zacks’ EPS averages are a mean average based on a survey of sell-side analysts that cover Azul.

Azul (NYSE:AZUL) last released its earnings results on Thursday, November 7th. The company reported $0.92 earnings per share for the quarter, beating the consensus estimate of $0.61 by $0.31. The business had revenue of $764.63 million for the quarter, compared to the consensus estimate of $790.71 million. Azul had a return on equity of 141.80% and a net margin of 1.85%.

AZUL has been the topic of several research reports. Raymond James raised their target price on Azul from $41.00 to $45.00 and gave the company an “outperform” rating in a research report on Tuesday, October 29th. Barclays set a $46.00 target price on Azul and gave the company a “hold” rating in a research report on Monday, August 12th. Deutsche Bank raised their target price on Azul from $43.00 to $48.00 and gave the company a “buy” rating in a research report on Friday, August 9th. ValuEngine upgraded Azul from a “strong sell” rating to a “sell” rating in a research report on Tuesday, October 29th. Finally, Buckingham Research upgraded Azul from a “neutral” rating to a “buy” rating and raised their target price for the company from $39.00 to $51.00 in a research report on Monday, October 28th. Two analysts have rated the stock with a sell rating, three have issued a hold rating and four have issued a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus target price of $41.18.

Shares of NYSE AZUL traded up $1.38 during midday trading on Tuesday, hitting $37.24. The stock had a trading volume of 230,710 shares, compared to its average volume of 476,560. The company has a market capitalization of $15.01 billion, a PE ratio of 23.42 and a beta of -0.51. The stock has a 50 day simple moving average of $37.65 and a 200-day simple moving average of $35.73. Azul has a 1 year low of $23.31 and a 1 year high of $43.14.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in AZUL. Daiwa Securities Group Inc. boosted its stake in Azul by 63.6% during the second quarter. Daiwa Securities Group Inc. now owns 900 shares of the company’s stock worth $30,000 after buying an additional 350 shares during the last quarter. NumerixS Investment Technologies Inc acquired a new position in Azul during the second quarter worth $33,000. Northern Trust Corp acquired a new position in Azul during the second quarter worth $216,000. Comerica Bank acquired a new position in Azul during the third quarter worth $219,000. Finally, Stevens Capital Management LP acquired a new position in Azul during the second quarter worth $274,000. 3.57% of the stock is currently owned by institutional investors.

About Azul

Azul SA provides passenger and cargo air transportation services in Brazil. As of March 31, 2018, it operated 739 daily flights to 106 destinations through a network of 206 non-stop routes with a fleet of 120 aircraft. The company was incorporated in 2008 and is headquartered in Barueri, Brazil.

Recommended Story: What is the role of the G-20?

Get a free copy of the Zacks research report on Azul (AZUL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Azul Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azul and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.